PT Kalbe Farma Tbk.

Symbol: PTKFY

PNK

17.03

USD

Market price today

  • 0.0056

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 3.94B

    MRK Cap

  • 0.03%

    DIV Yield

PT Kalbe Farma Tbk. (PTKFY) Financial Statements

On the chart you can see the default numbers in dynamics for PT Kalbe Farma Tbk. (PTKFY). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of PT Kalbe Farma Tbk., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019

balance-sheet.row.cash-and-short-term-investments

03397916.9263.9455.6
385.2
233.1

balance-sheet.row.short-term-investments

0165496.39.418.2
13.4
14.1

balance-sheet.row.net-receivables

05628331.7308.5249.4
256.6
266.4

balance-sheet.row.inventory

06791979.8460363.3
267.3
279.9

balance-sheet.row.other-current-assets

099495.744.437.2
24.2
29.1

balance-sheet.row.total-current-assets

015917724.11076.81105.6
933.3
808.4

balance-sheet.row.property-plant-equipment-net

08537934.7535.8586.3
607.2
575.8

balance-sheet.row.goodwill

0479347.430.914.8
13.9
21.1

balance-sheet.row.intangible-assets

01327234.21066868.8961154.4
523720.4
420475.6

balance-sheet.row.goodwill-and-intangible-assets

01806581.61546216.21170837.9
718946.3
713755.3

balance-sheet.row.long-term-investments

0285302.324.821.3
8.8
7.6

balance-sheet.row.tax-assets

0136102.68.26.5
6.1
8.9

balance-sheet.row.other-non-current-assets

0373922.8-1546106.4-1170751.6
-718891.1
-713696.3

balance-sheet.row.total-non-current-assets

011139844.1678.6700.4
677.3
651.3

balance-sheet.row.other-assets

0000
0
0

balance-sheet.row.total-assets

027057568.21755.41806
1610.5
1459.7

balance-sheet.row.account-payables

01690719.6128.7117.3
88.5
87.6

balance-sheet.row.short-term-debt

0299759.455.16.6
26.4
12.2

balance-sheet.row.tax-payables

0225196.613.819
22.9
9.4

balance-sheet.row.long-term-debt-total

0318778.918.534.5
51.6
46.7

Deferred Revenue Non Current

001.63
4.7
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-

balance-sheet.row.other-current-liab

01252689.587.9105.7
88.9
76.5

balance-sheet.row.total-non-current-liabilities

0694377.645.960.9
79.3
70.7

balance-sheet.row.other-liabilities

0000
0
0

balance-sheet.row.capital-lease-obligations

041907.51.63
4.7
0

balance-sheet.row.total-liab

03937546.2331.5309.7
306.1
256.4

balance-sheet.row.preferred-stock

0000
0
0

balance-sheet.row.common-stock

0468751.230.233
33.5
33.8

balance-sheet.row.retained-earnings

021162752.51300.81299.5
1186.6
1090.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

053.549.447.7
24.9
23.3

balance-sheet.row.other-total-stockholders-equity

0-212700.7-66.9-2.5
-2.6
-2.5

balance-sheet.row.total-stockholders-equity

021418856.51313.61377.7
1242.3
1144.8

balance-sheet.row.total-liabilities-and-stockholders-equity

027057568.21755.41806
1610.5
1459.7

balance-sheet.row.minority-interest

01701165.5110.3118.7
62.1
58.5

balance-sheet.row.total-equity

0231200221423.91496.3
1304.5
1203.4

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-

Total Investments

0450798.634.139.6
22.2
21.7

balance-sheet.row.total-debt

0618538.475.244.1
82.6
58.8

balance-sheet.row.net-debt

0-2613882.2-179.3-393.3
-289.1
-160.2

Cash Flow Statement

The financial landscape of PT Kalbe Farma Tbk. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019

cash-flows.row.net-income

0181.1228.4222.4
187.1
177

cash-flows.row.depreciation-and-amortization

047.949.447.1
43.6
36

cash-flows.row.deferred-income-tax

0000
0
0

cash-flows.row.stock-based-compensation

0000
0
0

cash-flows.row.change-in-working-capital

0000
0
0

cash-flows.row.account-receivables

0000
0
0

cash-flows.row.inventory

0000
0
0

cash-flows.row.account-payables

0000
0
0

cash-flows.row.other-working-capital

0000
0
0

cash-flows.row.other-non-cash-items

0-35.9-191.1-68.6
61.3
-31.2

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1178972.2-58.8-69.9
-76.6
-140

cash-flows.row.acquisitions-net

063609.6-44.982.8
1.5
10.6

cash-flows.row.purchases-of-investments

0-173704.2-8.6-17.5
-7.8
-0.7

cash-flows.row.sales-maturities-of-investments

04.716.78.5
9.2
0

cash-flows.row.other-investing-activites

0148275.5-0.30
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-1140786.7-95.93.8
-73.6
-130.1

cash-flows.row.debt-repayment

0-2513595.4-24.2-35.4
-18.1
-29.4

cash-flows.row.common-stock-issued

00-2.60
-2
0

cash-flows.row.common-stock-repurchased

00-67.70
-0.1
0

cash-flows.row.dividends-paid

0-1757714.4-110.2-91.7
-83.4
-86.1

cash-flows.row.other-financing-activites

03557244.6-6
33.9
56.3

cash-flows.row.net-cash-used-provided-by-financing-activities

0-2443986.3-160-133.1
-69.8
-59.1

cash-flows.row.effect-of-forex-changes-on-cash

0-40050.4237776.4-16432.5
51263.6
-51836.1

cash-flows.row.net-change-in-cash

0-717348.3-182.965.7
152.7
1.3

cash-flows.row.cash-at-end-of-period

03232420.6254.5437.4
371.7
219

cash-flows.row.cash-at-beginning-of-period

03949768.9437.4371.7
219
217.7

cash-flows.row.operating-cash-flow

0193.186.8200.9
292
181.8

cash-flows.row.capital-expenditure

0-1178972.2-58.8-69.9
-76.6
-140

cash-flows.row.free-cash-flow

0-1178779.228131
215.5
41.8

Income Statement Row

PT Kalbe Farma Tbk.'s revenue saw a change of NaN% compared with the previous period. The gross profit of PTKFY is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019

income-statement-row.row.total-revenue

030449134.11953.91834.5
1582.5
1598.2

income-statement-row.row.cost-of-revenue

018625888.51189.71073.3
906.1
896

income-statement-row.row.gross-profit

011823245.5764.2761.2
676.4
702.3

income-statement-row.row.gross-profit-ratio

0000
0
0

income-statement-row.row.research-development

0---
-
-

income-statement-row.row.selling-general-administrative

0---
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.other-expenses

0-6.3-15-15.6
-16.7
-16.4

income-statement-row.row.operating-expenses

08198108.5481.4483.3
436.5
470.3

income-statement-row.row.cost-and-expenses

0268239971671.11556.5
1342.5
1366.3

income-statement-row.row.interest-income

088217.65.57.7
10.4
7.8

income-statement-row.row.interest-expense

082958.23.74
6.1
2.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.total-other-income-expensenet

0-66015.418.311.5
8.4
8.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-

income-statement-row.row.other-operating-expenses

0-6.3-15-15.6
-16.7
-16.4

income-statement-row.row.total-operating-expenses

0-66015.418.311.5
8.4
8.3

income-statement-row.row.interest-expense

082958.23.74
6.1
2.9

income-statement-row.row.depreciation-and-amortization

0333650.249.447.1
43.6
36

income-statement-row.row.ebitda-caps

0---
-
-

income-statement-row.row.operating-income

03672252.6282.8277.9
240
231.9

income-statement-row.row.income-before-tax

03606237.2301.1289.4
248.4
240.3

income-statement-row.row.income-tax-expense

0827832.468.163.7
56.7
61.1

income-statement-row.row.net-income

02766748228.4222.4
187.1
177

Frequently Asked Question

What is PT Kalbe Farma Tbk. (PTKFY) total assets?

PT Kalbe Farma Tbk. (PTKFY) total assets is 27057568182323.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.370.

What is company free cash flow?

The free cash flow is -1793.009.

What is enterprise net profit margin?

The net profit margin is 0.089.

What is firm total revenue?

The total revenue is 0.123.

What is PT Kalbe Farma Tbk. (PTKFY) net profit (net income)?

The net profit (net income) is 2766748040055.000.

What is firm total debt?

The total debt is 618538351178.000.

What is operating expences number?

The operating expences are 8198108504360.000.

What is company cash figure?

Enretprise cash is 0.000.